No results for ‘’
Ajooni Biotech Ltd
NSE: AJOONI BSE: 535040
₹3.80
(0%)
Wed, 17 Jun 2026, 06:54 am
Market Cap (in Cr)0
PE Ratio15.50
Dividend0
Miscellaneous
Miscellaneous
24.5KAjooni Biotech Cashflow
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Deprecation and amortization | -4.92M | -5.78M | -11.11M | -10.05M | -8.74M | -10.94M |
| Accumulated depreciation, total | -12.59M | -16.96M | -26.66M | -36.76M | -45.50M | -56.44M |
| Cash from operating activities | -46.40M | 5.72M | 31.44M | -58.53M | 228.54M | -171.84M |
| Funds from operations | 8.60M | 9.32M | 24.26M | 22.40M | 33.28M | 45.46M |
| Net income (cash flow) | 3.47M | 3.73M | 10.49M | 11.25M | 21.61M | 33.72M |
| Depreciation & amortization (cash flow) | 3.51M | 4.37M | 11.11M | 10.05M | 8.74M | 10.94M |
| Depreciation/depletion | 3.51M | 4.37M | 9.70M | 10.05M | 8.74M | 10.94M |
| Amortization | — | — | 1.41M | — | — | — |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 279.05K | -95.41K | -1.45M | -3.41M | -5.42M | -8.77M |
| Changes in working capital | -55.00M | -3.60M | 7.18M | -80.93M | 195.27M | -217.29M |
| Cash from investing activities | 4.02M | -34.10M | -18.98M | -160.28M | 71.36M | -180.22M |
| Capital expenditures | -14.01M | -35.27M | -21.24M | -28.60M | -56.02M | -20.32M |
| Capital expenditures - fixed assets | -14.01M | -35.27M | -21.24M | -28.60M | -56.02M | -20.32M |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from financing activities | 36.31M | 29.58M | -14.33M | 221.33M | -30.09M | 251.61M |
| Free cash flow | -60.41M | -29.55M | 10.20M | -87.13M | 172.53M | -192.16M |